@article{53ef43720da4442c8abc2a5bf74ead39,
title = "Early-Onset Hydroxychloroquine Retinopathy and a Possible Relationship to Blood Levels: Comment on the Article by Petri et al",
author = "Naoto Yokogawa and Akiko Ohno-Tanaka and Masayuki Hashiguchi and Mikiko Shimizu and Hiroko Ozawa and Shinji Ueno and Kei Shinoda and Browning, {David J.}",
note = "Funding Information: . Dr. Yokogawa{\textquoteright}s work was supported by a Tokyo Metropolitan Government research grant. Dr. Browning{\textquoteright}s work was supported by the Diabetic Retinopathy Clinical Research Network. Dr. Ueno has received consulting fees and speaking fees from Sanofi (less than $10,000). Dr. Shinoda has received consulting fees and speaking fees from Sanofi (less than $10,000). Dr. Browning owns stock or stock options in Zeiss Meditec. No other disclosures relevant to this letter were reported",
year = "2021",
month = feb,
doi = "10.1002/art.41497",
language = "English",
volume = "73",
pages = "358--359",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "2",
}